Article info
PDFLaw, ethics and medicine
The ethical and legal implications of deactivating an implantable cardioverter-defibrillator in a patient with terminal cancer
- Correspondence to: MrJ Coggon Postgraduate Research Office, Cardiff Law School, Cardiff University, Museum Avenue, Cardiff CF10 3XJ, UK; coggonj{at}cf.ac.uk
Citation
The ethical and legal implications of deactivating an implantable cardioverter-defibrillator in a patient with terminal cancer
Publication history
- Received June 1, 2006
- Accepted September 1, 2006
- Revised July 20, 2006
- First published August 30, 2007.
Online issue publication
April 27, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2007 by the Journal of Medical Ethics
Other content recommended for you
- ICDs in end-stage heart failure
- Implantable cardioverter defibrillator deactivation and advance care planning: a focus group study
- Improving rates of implantable cardioverter defibrillator deactivation in end-of-life care
- Improving implantable cardioverter defibrillator deactivation discussions in admitted patients made DNR and comfort care
- ‘You can’t start a car when there’s no petrol left’: a qualitative study of patient, family and clinician perspectives on implantable cardioverter defibrillator deactivation
- Documented consent process for implantable cardioverter-defibrillators and implications for end-of-life care in older adults
- Implantable cardioverter defibrillators: risks accompany the life-saving benefits
- The long-term survival and the risks and benefits of implantable cardioverter defibrillators in patients with hypertrophic cardiomyopathy
- Current challenges in palliative care provision for heart failure in the UK: a survey on the perspectives of palliative care professionals
- My guardian angel: patients’ fears and desires related to discussing implantable cardioverter-defibrillator deactivation